Strategies to improve the implementation of preventive care in primary care: a systematic review and meta-analysis.
Laura Heath, Richard Stevens, Brian D Nicholson...
https://pubmed.ncbi.nlm.nih.gov/39334345/Actively Recruiting
Led by China National Center for Cardiovascular Diseases · Updated on 2026-02-10
100
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are evaluating the impact of an exercise prescription mini-program on the physical activity levels and related health indicators of patients with hypertension, hyperglycemia, hyperlipidemia, and hyperuricemia in primary healthcare settings in China. This six-month exploratory clinical trial aims to study how this digital intervention can affect patients with these Four Highs conditions, using exercise guidelines tailored to their needs. The study compares two groups one receiving an enhanced mini-program intervention that includes physician training, patient exercise guidance through the mini-program, and social support group activities and a control group where physicians receive training and provide exercise guidance independently. The intervention lasts for six months, focusing on behavior changes supported by technology and social interaction. Participants will be monitored for changes in their average daily step count, moderate-to-vigorous physical activity time, handgrip strength, body measurements, blood pressure, blood sugar, cholesterol, and uric acid levels over three months. Adherence to the exercise plan will be tracked through mini-program check-ins and social support attendance. The study involves regular assessments to understand the effects of exercise guidance supported by digital tools on managing these health conditions.
CONDITIONS
Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support Tools in the Management of Patients With "Four Highs" (Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia)
T
Tian
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
China National Center for Cardiovascular Diseases
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 3 months
Participants receive exercise guidance either through a mini-program with social support activities or autonomously, supported by physician training and assessments.
Regular visits as needed for guidance and assessments
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Laura Heath, Richard Stevens, Brian D Nicholson...
https://pubmed.ncbi.nlm.nih.gov/39334345/Jian Wu, Yifei Feng, Yuanyuan Zhao...
https://pubmed.ncbi.nlm.nih.gov/38650004/Sheila M Hegde, Scott D Solomon
https://pubmed.ncbi.nlm.nih.gov/26277725/Brent M Egan
https://pubmed.ncbi.nlm.nih.gov/28137989/Ilona Kickbusch, Dario Piselli, Anurag Agrawal...
https://pubmed.ncbi.nlm.nih.gov/34706260/Özge Kart, Vildan Mevsim, Alp Kut...
https://pubmed.ncbi.nlm.nih.gov/29187186/Wei Piao, Liyun Zhao, Yuxiang Yang...
https://pubmed.ncbi.nlm.nih.gov/36235748/Ben Singh, Mavra Ahmed, Amanda E Staiano...
https://pubmed.ncbi.nlm.nih.gov/38969775/Neil A Smart, David Downes, Tom van der Touw...
https://pubmed.ncbi.nlm.nih.gov/39331324/Graziella Zangger, Alessio Bricca, Behnam Liaghat...
https://pubmed.ncbi.nlm.nih.gov/37410534/China National Center for Cardiovascular Diseases
Lead Sponsor